# To read

* [Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy](https://www.nature.com/articles/s41375-020-0878-x)

* [The oncometabolite R-2-hydroxyglutarate activates NF-ÎºB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells](https://www.nature.com/articles/srep32428)

* [Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation](https://www-futuremedicine-com.proxy.insermbiblio.inist.fr/doi/10.2217/epi-2016-0008)

* [Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response](https://www-science-org.proxy.insermbiblio.inist.fr/doi/10.1126/scitranslmed.aax2863?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed)

* [2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity](https://www-science-org.proxy.insermbiblio.inist.fr/doi/10.1126/scitranslmed.aal2463)

* [Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis](https://mcr.aacrjournals.org/content/14/10/976.long)

* [The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism](https://pubmed-ncbi-nlm-nih-gov.proxy.insermbiblio.inist.fr/31221981/)

* [Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism](https://pubmed-ncbi-nlm-nih-gov.proxy.insermbiblio.inist.fr/32312817/)
